Merit Medical Systems, Inc. Profile Avatar - Palmy Investing

Merit Medical Systems, Inc.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company opera…
Medical - Instruments & Supplies
US, South Jordan [HQ]
Financials

Analysts

Earnings
Reported
Past Estimate Consensus
Future Estimate Consensus
EPS Revenue EBITDA EBIT SGA
FY EPS Revenue [mil.] Profit [mil.] EBITDA [mil.] EBIT [mil.] Expenses · SGA [mil.]
E E E E E E
All monetary values are presented in USD ($). E stands for Estimate.
2014 0.3900 0.565 449 464 16 17 31 62 31 31 128 127
2015 0.5300 0.853 509 542 22 20 40 64 40 32 147 135
2016 0.5400 0.995 542 606 23 18 38 71 38 32 156 168
2017 0.4500 1.270 603 724 20 22 34 82 35 28 184 197
2018 0.5600 1.661 727 880 27 38 45 118 45 53 229 253
2019 0.8000 1.413 882 989 42 5 60 129 59 16 276 356
2020 0.0990 1.556 994 956 5 90 38 113 39 24 327 287
2021 -0.1800 2.173 963 1,067 -9 32 44 105 45 41 297 228
2022 0.8600 2.576 1,074 1,147 48 45 172 133 78 60 335 267
2023 1.3100 2.971 1,150 1,253 74 94 194 146 101 66 342 294
2024 1.6400 3.354 1,253 1,348 94 195 223 159 121 34 317 404
2025 - 3.709 - 1,468 - 217 - 174 - 37 - 441
2026 - 4.119 - 1,549 - 2.F12X/td> - 2.F121/td> - 2.F121 - 2.F121
2027 - 4.485 - 1,673 - 1.F13X/td> - 1.F131/td> - 1.F131 - 1.F131
2028 - 4.890 - 1,787 - 0.F14X/td> - 0.F141/td> - 0.F141 - 0.F141
Institutional Sentiment
Morgan Stanley
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
JP Morgan Chase
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
Citigroup
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
Overall Consensus
Grading Consensus
Click to each, to see the grade
Price Target Consensus

-4.818% $5.06 · MISS

Nov. 6, 2024
Price Then
$98.79
Price Target
$110.09
Price Now
$105.03
End of MMSI's Analysis
CIK: 856982 CUSIP: 589889104 ISIN: US5898891040 LEI: - UEI: -
Secondary Listings
MMSI has no secondary listings inside our databases.